Akèy › Leukemi › Ohio › Columbus
Etid klinik pou Leukemi nan Columbus, OH
12 etid pou Leukemi ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Ap rekriteFaz 3
- Quetzal Site 8, Columbus
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Ap rekriteFaz 1/2
- Ohio State University, Columbus
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- Ohio State University Comprehensive Cancer Center, Columbus
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Ap rekriteFaz 3
- Ohio State University, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Ap rekriteFaz 1/2
- The Ohio State University Wexner Medical Center, Columbus
Hairy Cell Leukemia Patient Data Registry
Ap rekriteEtid obsèvasyon
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Ap rekriteFaz 1/2
- Dren Investigational Site, Columbus
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Ap rekriteFaz 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Ap rekriteFaz 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Ap rekriteFaz 1
- The James Cancer Hospital and Solove Research Institute, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Columbus
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Ap rekriteFaz 1
- The Ohio State University Wexner Medical Center - James Cancer Hosp, Columbus
Etid Leukemi nan lòt vil
- Houston, TX28 etid
- Boston, MA25 etid
- New York City, NY19 etid
- Chicago, IL16 etid
- Los Angeles, CA16 etid
- Durham, NC13 etid
- Nashville, TN12 etid
- Baldwin Park, CA12 etid
- Philadelphia, PA12 etid
- Seattle, WA11 etid
- Atlanta, GA11 etid
- Milwaukee, WI11 etid
Lòt etid nan Columbus
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete39 etid
- Kansè ovè39 etid
- Kansè (tout kalite)38 etid
- Kansè poumon36 etid
- Leksemi mieloïd egi34 etid
- Lukemi lenfositè kwonik28 etid
- Kansè Metastatik27 etid
- Kansè Endomèt25 etid
- Kansè pwostat24 etid
- Myelom Miltip24 etid
- Kansè kolorektal24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.